Related references
Note: Only part of the references are listed.Improved Accuracy of Cefepime Susceptibility Testing for Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae with an On-Demand Digital Dispensing Method
Kenneth P. Smith et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae
Joshua T. Thaden et al.
VIRULENCE (2017)
In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae
Laurent Poirel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae
James Albiero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae
A. Oliva et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
How inkjet printing technology can defeat multidrug-resistant pathogens
Kenneth P. Smith et al.
FUTURE MICROBIOLOGY (2016)
Verification of an Automated, Digital Dispensing Platform for At-Will Broth Microdilution-Based Antimicrobial Susceptibility Testing
Kenneth P. Smith et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2016)
Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections A Systematic Review and Meta-Analysis
Wentao Ni et al.
MEDICINE (2016)
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013
Alice Y. Guh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
Haley J. Morrill et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management
Elizabeth Temkin et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS: INFECTIOUS DISEASES OF CURRENT AND EMERGING CONCERN (2014)
Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae by In Vitro Time-Kill Experiments
T. Tangden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A Review of Intravenous Minocycline for Treatment of Multidrug-Resistant Acinetobacter Infections
David J. Ritchie et al.
CLINICAL INFECTIOUS DISEASES (2014)
Carbapenem-Resistance in Gram-Negative Bacilli and Intravenous Minocycline: An Antimicrobial Stewardship Approach at the Detroit Medical Center
Jason M. Pogue et al.
CLINICAL INFECTIOUS DISEASES (2014)
Options for treating carbapenem-resistant Enterobacteriaceae
Petros I. Rafailidis et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2014)
Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study
Marcelle D. Alves et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Combination therapy for carbapenem-resistant Gram-negative bacteria
Mical Paul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
To Add or Not To Add Polysorbate 80: Impact on Colistin MICs for Clinical Strains of Enterobacteriaceae and Pseudomonas aeruginosa and Quality Controls
Christina A. Sutherland et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
When Does 2 Plus 2 Equal 5? A Review of Antimicrobial Synergy Testing
Christopher D. Doern
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Systematic Review and Meta-Analysis of In Vitro Synergy of Polymyxins and Carbapenems
Oren Zusman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant KPC-Producing Klebsiella pneumoniae
Carlo Tascini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae
Sarah A. Clock et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Colistin MIC Variability by Method for Contemporary Clinical Isolates of Multidrug-Resistant Gram-Negative Bacilli
Janet A. Hindler et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Assessment of Antimicrobial Combinations for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
Elizabeth B. Hirsch et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae
Meredith G. Jernigan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
G. L. Daikos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae
George A. Pankey et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae
Beatrice Bercot et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae
Azza Elemam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Susceptibility testing of unconventional antibiotics against multiresistant Acinetobacter spp. by agar dilution and Vitek 2
Thean Yen Tan et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Tigecycline: A glycylcycline antimicrobial agent
Thien-Ly Doan et al.
CLINICAL THERAPEUTICS (2006)
Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY:: molecular epidemiology and in vitro activity of polymyxin B and other agents
S Bratu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects
G Muralidharan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology
AM Queenan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936)
CJ Henwood et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Share Paper
